We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.78%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.48B
AUM Growth
+$121M
Cap. Flow
+$68.3M
Cap. Flow %
1.96%
Top 10 Hldgs %
12.54%
Holding
1,594
New
179
Increased
532
Reduced
584
Closed
199

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$8.12M
2
KMI icon
Kinder Morgan
KMI
+$7.34M
3
ILMN icon
Illumina
ILMN
+$6.91M
4
DD icon
DuPont de Nemours
DD
+$6.77M
5
NVGS icon
Navigator Holdings
NVGS
+$6.1M

Sector Composition

Rank Sector Weight
1 Healthcare 12.04%
2 Industrials 10.15%
3 Energy 9.83%
4 Financials 9.31%
5 Technology 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
226
CVS Health
CVS
$134B
$3.77M 0.11%
39,114
+10,490
+37% +$924K
REGN icon
227
Regeneron Pharmaceuticals
REGN
$77.4B
$3.76M 0.11%
9,174
-716
-7% -$282K
PAA icon
228
Plains All American Pipeline
PAA
$17.5B
$3.76M 0.11%
73,240
-18,347
-20% -$975K
ORCL icon
229
Oracle
ORCL
$367B
$3.73M 0.11%
82,952
-11,885
-13% -$484K
PNR icon
230
Pentair
PNR
$10.6B
$3.71M 0.11%
83,155
+5,306
+7% +$233K
MMP
231
DELISTED
Magellan Midstream Partners, L.P.
MMP
$3.7M 0.11%
44,767
-984
-2% -$80.4K
IBB icon
232
iShares Biotechnology ETF
IBB
$9.52B
$3.68M 0.11%
36,435
-17,811
-33% -$1.73M
WSM icon
233
Williams-Sonoma
WSM
$27.5B
$3.64M 0.1%
96,242
+1,004
+1% +$34.8K
CL icon
234
Colgate-Palmolive
CL
$73.3B
$3.63M 0.1%
52,463
-1,299
-2% -$87.7K
ADP icon
235
Automatic Data Processing
ADP
$105B
$3.58M 0.1%
42,974
-6,997
-14% -$567K
BIIB icon
236
Biogen
BIIB
$30.7B
$3.58M 0.1%
10,546
-847
-7% -$274K
RTN
237
DELISTED
Raytheon Company
RTN
$3.56M 0.1%
32,902
-220
-0.7% -$22.7K
GPRO icon
238
GoPro
GPRO
$124M
$3.55M 0.1%
56,201
+3,158
+6% +$233K
CLB icon
239
Core Laboratories
CLB
$477M
$3.53M 0.1%
29,318
-2,434
-8% -$320K
TTP
240
DELISTED
TORTOISE PIPELINE & ENERGY FUND, INC.
TTP
$3.51M 0.1%
28,532
+267
+0.9% +$33.9K
LVS icon
241
Las Vegas Sands
LVS
$32.3B
$3.5M 0.1%
60,223
+38,861
+182% +$2.34M
LGCY
242
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$3.5M 0.1%
305,965
+100,561
+49% +$1.92M
DVA icon
243
DaVita
DVA
$15.3B
$3.48M 0.1%
45,884
+6,741
+17% +$508K
RHP icon
244
Ryman Hospitality Properties
RHP
$8.41B
$3.43M 0.1%
65,114
+1,682
+3% +$83.8K
FNGN
245
DELISTED
Financial Engines, Inc.
FNGN
$3.42M 0.1%
93,585
+67,435
+258% +$2.33M
BDX icon
246
Becton Dickinson
BDX
$45.6B
$3.42M 0.1%
23,825
-4,923
-17% -$630K
MCK icon
247
McKesson
MCK
$101B
$3.39M 0.1%
16,340
+5,667
+53% +$1.15M
FAF icon
248
First American
FAF
$7.71B
$3.38M 0.1%
+99,605
New +$3.05M
WMB icon
249
Williams Companies
WMB
$86.7B
$3.36M 0.1%
74,789
-12,929
-15% -$661K
DVY icon
250
iShares Select Dividend ETF
DVY
$23.6B
$3.35M 0.1%
42,128
-4,796
-10% -$370K

Similar funds

Oppenheimer & Co's Q4 2014 Portfolio in Review

As of Q4 2014, Oppenheimer & Co held 1,594 positions worth $3.48B, up 3.6% from $3.36B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Oppenheimer & Co's Q4 2014 filing shows 179 new, 532 increased, 584 reduced and 199 closed positions. Its largest new stake was First American: 99,605 shares worth $3.38M. The largest sale was IBM, an estimated $5.56M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Industrials and Energy.

  • Oppenheimer & Co's largest Q4 2014 buy was First American: 99,605 shares worth $3.38M.
  • Oppenheimer & Co added most to Alibaba in Q4 2014, an estimated $8.12M increase.
  • Oppenheimer & Co's biggest Q4 2014 reduction was IBM, cutting an estimated $5.56M.
  • Oppenheimer & Co fully exited Tesla in Q4 2014, selling an estimated $4.59M.
  • Oppenheimer & Co's ten largest holdings make up 13% of its $3.48B portfolio in Q4 2014.
  • Oppenheimer & Co opened 179 new positions and closed 199 in Q4 2014.
  • Oppenheimer & Co's portfolio value rose 3.6% quarter-over-quarter to $3.48B.

Based on Oppenheimer & Co's 13F filing for Q4 2014, filed 10 Feb 2015.